Bio-Techne Named "Researchers' Choice" by CiteAb

MINNEAPOLIS, Feb. 7, 2018 /PRNewswire/ -- Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, was honored with the prestigious 2018 CiteAb Award for Researchers' Choice. The CiteAb Awards aim to celebrate the very best suppliers and individuals in the research reagent sector worldwide and have been running for four years.


For the 2018 awards, the scope of the coveted Researchers' Choice Award was widened to include suppliers from across numerous reagent types. This award truly reflects what researchers think about the companies they use for their research. It was noted that Bio-Techne stood out to the judges in this category. Bio-Techne and its family of world-class brands including R&D Systems, Novus Biologicals, Tocris Bioscience, Boston Biochem, Trevigen, ProteinSimple, BiosPacific, Cliniqa and Advanced Cell Diagnostics, received numerous nominations from researchers around the world, all outlining the excellent quality of products and standards of service they have experienced.

Dr Andrew Chalmers, Founder of CiteAb, said: "This is always one of the most competitive categories in the awards, but we've never seen one company get quite so many nominations as Bio-Techne did this year. Clearly the company has a very loyal customer base, earned through providing excellent products. Congratulations to Bio-Techne!"

Bio-Techne was also recognized in The Innovative Product of the Year Category, being highly commended for its range of Janelia Fluor® Dyes from Tocris Bioscience. Janelia Fluor® Dyes are very bright and photo-stable fluorescent dyes for superior, high-resolution biological imaging.

Dave Eansor, Senior Vice President of the Biotech Division of Bio-Techne, commented, "We are honored and delighted at the recognition we have received from Life Science researchers around the world. Our global team across the biotechnology, diagnostics, and protein platform divisions are committed to product innovation, unsurpassed quality, performance, and reliability. This commitment enables our customers to advance scientific breakthroughs and encourages us to maintain the highest levels of technical support and customer service. We also look forward to serving the scientific community through our recent acquisitions of Trevigen and Atlanta Biologicals."

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteins––notably cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds and ACD's in situ hybridization detection products---which are sold to biomedical researchers and clinical research laboratories; these operations constitute the core Biotechnology Division, headquartered in Minneapolis, Minnesota. The Protein Platforms Division manufactures innovative protein analysis tools under the ProteinSimple brand name that greatly automate western blotting and immunoassay practices. The Diagnostics Division manufactures FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM customer and clinical customers. Bio-Techne products are integral components of scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $563 million in net sales in fiscal 2017 and has approximately 1,800 employees worldwide. For more information on Bio-Techne and its brands, please visit

Contact: Dave Eansor, Senior Vice President, Biotech Division, 612-379-2956


Cision View original content with multimedia:

SOURCE Bio-Techne Corporation